facebook linkedin twitter

Moderna Expanding Kids Vaccine Study to Better Assess Safety

July 27, 2021by Matthew Perrone and Linda A. Johnson, Associated Press
In this March 29, 2021 file photo, a worker readies syringes with the Moderna COVID-19 vaccine in Metairie, La. (AP Photo/Gerald Herbert, File)

WASHINGTON (AP) — Moderna said Monday it plans to expand the size of its COVID-19 vaccine study in younger children to better detect rare side effects, such as a type of heart inflammation recently flagged by U.S. health authorities.

The company said it is in talks with the Food and Drug Administration to enroll more study participants under age 12. It had intended to test the vaccine in about 7,000 children, with some as young as 6 months. The Cambridge, Massachusetts-based company said via email it hasn’t decided on how many kids might be added. 

The announcement comes as U.S. COVID-19 cases are rising and schools prepare to welcome students back to classrooms. At the same time, regulators continue to review cases of a rare type of heart inflammation called myocarditis that has been reported in a small number of teenagers who got the Moderna or Pfizer shots.

Pfizer said on Monday that if it makes changes to its vaccine testing in children, it will provide an update then. The New York-based company is testing its vaccine in up to 4,500 children in the United States and Europe.

The FDA said in a statement it could not comment on its discussions with companies, but added “we do generally work with sponsors to ensure the number of participants in clinical trials are of adequate size to detect safety signals.”

The news was first reported by the New York Times.

U.S. officials and independent medical experts said last month the benefits of the vaccines far outweigh the risks of the side effect, which has been reported in several hundred people younger than 30. But any vaccine safety issues could slow uptake, particularly among parents wary of taking any health risk with their children.

Currently, Pfizer has the only U.S. vaccine authorized for children 12 years and up, while Moderna is expecting an FDA ruling on its application in the coming days.

While teens receive the same dose as adults, younger children may need smaller doses. That additional complexity adds time to drugmakers’ research and application timelines.

Moderna said Monday it expects to have enough data to apply for FDA authorization in younger kids by late this year or early 2022. 

Pfizer has previously said it expects to apply in September for children ages 5 through 11. Results for two younger age groups that began testing a little later should be available by October or November, according to the company.

___

 Johnson reported from Fairless Hills, Pennsylvania.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

A+
a-

Health

December 8, 2021
by Alexa Hornbeck
White House to Implement Policy to Cover the Cost of COVID-19 Testing

WASHINGTON — President Joe Biden recently implemented new actions to protect Americans against COVID-19 variants this winter, including a new... Read More

WASHINGTON — President Joe Biden recently implemented new actions to protect Americans against COVID-19 variants this winter, including a new policy beginning Jan. 15 to expand at-home testing. “More than 150 million Americans with private insurance, who are now able to get tests covered in physician... Read More

December 8, 2021
by Alexa Hornbeck
Digital Health Companies Look to Improve Access to Culturally Competent Care

The COVID-19 pandemic has transformed the use of telehealth and now many digital health companies are seeking to revolutionize access... Read More

The COVID-19 pandemic has transformed the use of telehealth and now many digital health companies are seeking to revolutionize access to care for communities of color.  “I saw all these different solutions popping up and wondered how I could fine tune these innovations to what Black... Read More

Pfizer Says COVID Booster Offers Protection Against Omicron

Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may offer important protection against the new omicron variant even though... Read More

Pfizer said Wednesday that a booster dose of its COVID-19 vaccine may offer important protection against the new omicron variant even though the initial two doses appear significantly less effective. Pfizer and its partner BioNTech said that while two doses may not be protective enough to prevent infection,... Read More

December 6, 2021
by Brock Blasdell
NYC to Expand COVID-19 Vaccination Mandates to Children

NEW YORK — Mayor Bill de Blasio announced on Monday that, in an effort to combat the omicron variant, children... Read More

NEW YORK — Mayor Bill de Blasio announced on Monday that, in an effort to combat the omicron variant, children aged 5-11 will soon be required to present proof of at least one COVID-19 vaccination before they can enter any private indoor business within New York... Read More

December 5, 2021
by Dan McCue
Dobbs Now Supreme Court’s Most Anticipated Decision In Years

WASHINGTON — It wasn’t even the top headline in The New York Times the day after the decision was announced.... Read More

WASHINGTON — It wasn’t even the top headline in The New York Times the day after the decision was announced. That distinction went to the death of former President Lyndon Baines Johnson, who had died at age 64 after suffering a heart attack at his ranch... Read More

Omicron May Be Driving South Africa's Surge; Wary World Watches

JOHANNESBURG (AP) — Dr. Sikhulile Moyo was analyzing COVID-19 samples in his lab in Botswana last week when he noticed... Read More

JOHANNESBURG (AP) — Dr. Sikhulile Moyo was analyzing COVID-19 samples in his lab in Botswana last week when he noticed they looked startlingly different from others. Within days, the world was ablaze with the news that the coronavirus had a new variant of concern, which appears to be... Read More

News From The Well
scroll top